These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 31112821)

  • 1. Systematic profiling of SH3-mediated Tau-Partner interaction network in Alzheimer's disease by integrating in silico analysis and in vitro assay.
    Wang X; Chang C; Wang D; Hong S
    J Mol Graph Model; 2019 Jul; 90():265-272. PubMed ID: 31112821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tau-S214 Phosphorylation Inhibits Fyn Kinase Interaction and Increases the Decay Time of NMDAR-mediated Current.
    Jos S; Poulose R; Kambaru A; Gogoi H; Dalavaikodihalli Nanjaiah N; Padmanabhan B; Mehta B; Padavattan S
    J Mol Biol; 2024 Feb; 436(4):168445. PubMed ID: 38218365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A peptide inhibitor of Tau-SH3 interactions ameliorates amyloid-β toxicity.
    Rush T; Roth JR; Thompson SJ; Aldaher AR; Cochran JN; Roberson ED
    Neurobiol Dis; 2020 Feb; 134():104668. PubMed ID: 31698056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Src homology 3 domain-binding motifs identified from proteomic screen of a Pro-rich region.
    Jia CY; Nie J; Wu C; Li C; Li SS
    Mol Cell Proteomics; 2005 Aug; 4(8):1155-66. PubMed ID: 15929943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical residues involved in tau binding to fyn: implications for tau phosphorylation in Alzheimer's disease.
    Lau DH; Hogseth M; Phillips EC; O'Neill MJ; Pooler AM; Noble W; Hanger DP
    Acta Neuropathol Commun; 2016 May; 4(1):49. PubMed ID: 27193083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cgamma1, Grb2, and Src family kinases.
    Reynolds CH; Garwood CJ; Wray S; Price C; Kellie S; Perera T; Zvelebil M; Yang A; Sheppard PW; Varndell IM; Hanger DP; Anderton BH
    J Biol Chem; 2008 Jun; 283(26):18177-86. PubMed ID: 18467332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diverse recognition of non-PxxP peptide ligands by the SH3 domains from p67(phox), Grb2 and Pex13p.
    Kami K; Takeya R; Sumimoto H; Kohda D
    EMBO J; 2002 Aug; 21(16):4268-76. PubMed ID: 12169629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tyrosine phosphorylation of tau regulates its interactions with Fyn SH2 domains, but not SH3 domains, altering the cellular localization of tau.
    Usardi A; Pooler AM; Seereeram A; Reynolds CH; Derkinderen P; Anderton B; Hanger DP; Noble W; Williamson R
    FEBS J; 2011 Aug; 278(16):2927-37. PubMed ID: 21692989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AlphaScreen HTS and live-cell bioluminescence resonance energy transfer (BRET) assays for identification of Tau-Fyn SH3 interaction inhibitors for Alzheimer disease.
    Cochran JN; Diggs PV; Nebane NM; Rasmussen L; White EL; Bostwick R; Maddry JA; Suto MJ; Roberson ED
    J Biomol Screen; 2014 Dec; 19(10):1338-49. PubMed ID: 25156556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformation and Affinity Modulations by Multiple Phosphorylation Occurring in the BIN1 SH3 Domain Binding Site of the Tau Protein Proline-Rich Region.
    Lasorsa A; Bera K; Malki I; Dupré E; Cantrelle FX; Merzougui H; Sinnaeve D; Hanoulle X; Hritz J; Landrieu I
    Biochemistry; 2023 Jun; 62(11):1631-1642. PubMed ID: 37167199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the SH3 domain of human osteoclast-stimulating factor with rationally designed peptoid inhibitors.
    Han S; Liu Q; Wang F; Yuan Z
    J Pept Sci; 2016 Aug; 22(8):533-9. PubMed ID: 27443979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of the interaction between the neuronal BIN1 isoform 1 and Tau proteins - role of the SH3 domain.
    Malki I; Cantrelle FX; Sottejeau Y; Lippens G; Lambert JC; Landrieu I
    FEBS J; 2017 Oct; 284(19):3218-3229. PubMed ID: 28755476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the systematic effect of N-substituted PxxP motifs on peptoid affinity to ARHGEF5/TIM SH3 domain and its relationship with ARHGEF5/TIM activation.
    Fu Y; He P; Zhou Y; Huang S; Liang L; Liu S
    Proteins; 2019 Nov; 87(11):979-991. PubMed ID: 31197859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acan125 binding to the SH3 domain of acanthamoeba myosin-IC.
    Zot HG; Bhaskara V; Liu L
    Arch Biochem Biophys; 2000 Mar; 375(1):161-4. PubMed ID: 10683262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tau phosphorylation regulates the interaction between BIN1's SH3 domain and Tau's proline-rich domain.
    Sottejeau Y; Bretteville A; Cantrelle FX; Malmanche N; Demiaute F; Mendes T; Delay C; Alves Dos Alves H; Flaig A; Davies P; Dourlen P; Dermaut B; Laporte J; Amouyel P; Lippens G; Chapuis J; Landrieu I; Lambert JC
    Acta Neuropathol Commun; 2015 Sep; 3():58. PubMed ID: 26395440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular design and optimization of hepatic cancer SLP76-derived PLCγ1 SH3-binding peptide with the systematic N-substitution of peptide PXXP motif.
    Tang W; Zhao Z; Wang C; Ye T; Yang B
    J Mol Recognit; 2019 Dec; 32(12):e2806. PubMed ID: 31397025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated In Silico-In Vitro Identification and Characterization of the SH3-Mediated Interaction between Human PTTG and its Cognate Partners in Medulloblastoma.
    Liu J; Wang D; Li Y; Yao H; Zhang N; Zhang X; Zhong F; Huang Y
    Cell Biochem Biophys; 2018 Jun; 76(1-2):83-90. PubMed ID: 28646413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of the proline-rich segment of myelin basic protein to SH3 domains: spectroscopic, microarray, and modeling studies of ligand conformation and effects of posttranslational modifications.
    Polverini E; Rangaraj G; Libich DS; Boggs JM; Harauz G
    Biochemistry; 2008 Jan; 47(1):267-82. PubMed ID: 18067320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The SH3 domain of a M7 interacts with its C-terminal proline-rich region.
    Wang Q; Deloia MA; Kang Y; Litchke C; Zhang N; Titus MA; Walters KJ
    Protein Sci; 2007 Feb; 16(2):189-96. PubMed ID: 17189480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving SH3 domain ligand selectivity using a non-natural scaffold.
    Nguyen JT; Porter M; Amoui M; Miller WT; Zuckermann RN; Lim WA
    Chem Biol; 2000 Jul; 7(7):463-73. PubMed ID: 10903934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.